Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

642 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Preventing severe hypoglycemia in adults with type 2 diabetes (PHT2): Design, delivery and evaluation framework for a randomized controlled trial.
Ralston JD, Anderson M, Ng J, Bashir A, Ehrlich K, Burns-Hunt D, Cotton M, Hansell L, Hsu C, Hunt H, Karter AJ, Levy SM, Ludman E, Madziwa L, Omura EM, Rogers K, Sevey B, Shaw JAM, Shortreed SM, Singh U, Speight J, Sweeny A, Tschernisch K, Sergei Tschernisch S, Yarborough L. Ralston JD, et al. Among authors: cotton m. Contemp Clin Trials. 2024 Apr;139:107456. doi: 10.1016/j.cct.2024.107456. Epub 2024 Jan 20. Contemp Clin Trials. 2024. PMID: 38253252 Clinical Trial.
A review of the use of Irlen (tinted) lenses.
Cotton MM, Evans KM. Cotton MM, et al. Aust N Z J Ophthalmol. 1990 Aug;18(3):307-12. doi: 10.1111/j.1442-9071.1990.tb00625.x. Aust N Z J Ophthalmol. 1990. PMID: 2261178 Review.
Challenges faced by frugal surgical innovations.
Sharma D, Mairal A, Prabhu J, Cotton M. Sharma D, et al. Among authors: cotton m. Trop Doct. 2024 May 16:494755241253098. doi: 10.1177/00494755241253098. Online ahead of print. Trop Doct. 2024. PMID: 38752260 No abstract available.
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study.
Rodriguez CA, Natukunda E, Strehlau R, Venter EL, Rungmaitree S, Cunningham CK, Lalloo U, Kosalaraksa P, HellstrÖm E, Liberty A, McGrath EJ, Kaur M, Leisegang R, Hindman JT, Vieira VA, Kersey K, Cotton MF, Rakhmanina N, Gaur AH. Rodriguez CA, et al. Among authors: cotton mf. Lancet HIV. 2024 May;11(5):e300-e308. doi: 10.1016/S2352-3018(23)00327-2. Epub 2024 Apr 12. Lancet HIV. 2024. PMID: 38621393 Clinical Trial.
Advocacy for surgeons: Ensuring excellence in patient care.
Zadey S, Sharma D, Cotton M. Zadey S, et al. Among authors: cotton m. Trop Doct. 2024 Apr;54(2):85-87. doi: 10.1177/00494755241237599. Epub 2024 Mar 8. Trop Doct. 2024. PMID: 38456731 No abstract available.
Paediatric abacavir-lamivudine fixed-dose dispersible tablets and ritonavir-boosted lopinavir granules in neonates exposed to HIV (PETITE study): an open-label, two-stage, single-arm, phase 1/2, pharmacokinetic and safety trial.
Bekker A, Salvadori N, Rabie H, du Toit S, Than-In-At K, Groenewald M, Cressey R, Nielsen J, Capparelli EV, Lallemant M, Cotton MF, Cressey TR; PETITE-ABC/3TC-LPVr Study Team. Bekker A, et al. Among authors: cotton mf. Lancet HIV. 2024 Feb;11(2):e86-e95. doi: 10.1016/S2352-3018(23)00289-8. Lancet HIV. 2024. PMID: 38296364 Clinical Trial.
642 results